Human immunodeficiency virus-associated vasculopathy in transgenic mice
- PMID: 9151876
- PMCID: PMC191704
- DOI: 10.1128/JVI.71.6.4809-4814.1997
Human immunodeficiency virus-associated vasculopathy in transgenic mice
Abstract
There is substantial clinical evidence for the development of vascular disorders in human immunodeficiency virus (HIV)-infected individuals, particularly in the form of vasculitis. Transgenic mice carrying a replication-defective HIV-1 provirus with selective deletion of the gag, pol, and env genes developed extensive vasculopathy. Restricted expression of HIV nonstructural genes in smooth muscle cells was accompanied by the migration and proliferation of these cells in blood vessels of all sizes and at different body sites. The frequent infiltration observed in the hypertrophic vessel walls occurred predominantly in the adventitia and was composed of primarily T cells and occasionally plasma cells. The intimal thickening generated significant luminal narrowing in some vessels, and the restricted blood flow led to ischemia in the affected tissues. Interestingly, the endothelium did not appear to support HIV gene expression or be involved in the pathological process. This transgenic model provides an opportunity to dissect the mechanism underlying HIV-associated vasculopathy.
Similar articles
-
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.J Virol. 1996 May;70(5):3198-206. doi: 10.1128/JVI.70.5.3198-3206.1996. J Virol. 1996. PMID: 8627800 Free PMC article.
-
Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef.Kidney Int. 2000 Sep;58(3):1148-59. doi: 10.1046/j.1523-1755.2000.00271.x. Kidney Int. 2000. PMID: 10972678
-
Transgenic dissection of HIV genes involved in lymphoid depletion.J Clin Invest. 1997 Jul 1;100(1):32-9. doi: 10.1172/JCI119518. J Clin Invest. 1997. PMID: 9202054 Free PMC article.
-
Transgenic models of human immunodeficiency virus type-1.Curr Top Microbiol Immunol. 1996;206:197-222. doi: 10.1007/978-3-642-85208-4_11. Curr Top Microbiol Immunol. 1996. PMID: 8608718 Review.
-
Transgenic mice as models of human immunodeficiency virus expression and related cellular effects.J Gen Virol. 1994 Oct;75 ( Pt 10):2549-58. doi: 10.1099/0022-1317-75-10-2549. J Gen Virol. 1994. PMID: 7931142 Review. No abstract available.
Cited by
-
Virus vasculopathy and stroke: an under-recognized cause and treatment target.Infect Disord Drug Targets. 2010 Apr;10(2):105-11. doi: 10.2174/187152610790963537. Infect Disord Drug Targets. 2010. PMID: 20166970 Free PMC article. Review.
-
Infection-related vasculitis.Curr Rheumatol Rep. 2005 Aug;7(4):281-7. doi: 10.1007/s11926-005-0038-3. Curr Rheumatol Rep. 2005. PMID: 16045831 Review.
-
The role of infectious agents in the pathogenesis of vasculitis.Best Pract Res Clin Rheumatol. 2008 Oct;22(5):897-911. doi: 10.1016/j.berh.2008.09.009. Best Pract Res Clin Rheumatol. 2008. PMID: 19028370 Free PMC article. Review.
-
HIV infection and stroke: current perspectives and future directions.Lancet Neurol. 2012 Oct;11(10):878-90. doi: 10.1016/S1474-4422(12)70205-3. Lancet Neurol. 2012. PMID: 22995692 Free PMC article. Review.
-
Dilation of the aortic root in children infected with human immunodeficiency virus type 1: The Prospective P2C2 HIV Multicenter Study.Am Heart J. 2001 Apr;141(4):661-70. doi: 10.1067/mhj.2001.113757. Am Heart J. 2001. PMID: 11275935 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical